-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Biopharma Q2 EPS $(0.30) Up From $(32.23) YoY

Benzinga·02/17/2026 21:59:49
Listen to the news
Propanc Biopharma (NASDAQ:PPCB) reported quarterly losses of $(0.30) per share. This is a 99.07 percent increase over losses of $(32.23) per share from the same period last year.